Some people suffer from repeated attacks of malaria. These can occur weeks to months or longer after contracting the disease. The phenomenon is only too familiar to those who were bitten by mosquitoes carrying the type of ...
Jan 14, 2019
0
4
After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria. The technology is promising, say vaccine ...
Apr 8, 2022
0
7
A new drug that can cure a certain type of malaria was approved in Australia on Monday for kids and teens.
Mar 14, 2022
0
14
In an article published in the journal eLife, researchers at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, describe a novel strategy for detecting imbalances and complications in patients infected ...
Dec 23, 2021
1
35
Walter Reed Army Institute of Research (WRAIR) researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model.
Feb 26, 2016
0
13
A new approach could illuminate a critical stage in the life cycle of one of the most common malaria parasites. The approach was developed by scientists at Kyoto University's Institute for Integrated Cell-Material Sciences ...
Jul 3, 2020
0
131
(Medical Xpress)—Researchers in Australia have found that a protein in platelets found naturally in blood has a protective effect against malaria. In their paper published in the journal Science, the team describes how ...
Currently, few antimalarial treatments exist that effectively kill liver-stage malaria parasites, which can lay dormant for months or years as in the case of Plasmodium vivax. Researchers from Kanazawa University have successfully ...
Dec 12, 2018
0
0
Unusually high levels of blood congestion in vessels feeding the brain may lead to severe swelling, scientists have found in a discovery that solves a longstanding malaria mystery: how the infection deleteriously impacts ...
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...
Sep 21, 2018
0
38
